Biopharma · FDA Approvals · Stock

ARAY Accuray

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors thro…

Assets on file: CyberKnife

Start live analysis of ARAY Run 8-agent AI analysis All sector events →

Catalyst calendar

Dated catalysts for ARAY, including recently decided ones.

Nothing scheduled in this window.

Recent first-hand events

Every first-hand event for ARAY, newest first.

Instant stream — events appear as soon as they are filed.

Decision-gradeMaterialNotableMinor

Sep 27, 2026

11:15 PM

ARAYAccuray

Accuray partners with Samsung NeuroLogica on volumetric imaging for CyberKnife

Accuray entered into agreements with Samsung NeuroLogica to develop advanced volumetric imaging capabilities for the CyberKnife System. The collaboration couples Samsung's mobile CT and volumetric imaging expertise with Accuray's precision radiosurgery and motion management technology. No commercial product has been announced and future developments remain subject to regulatory requirements.

Partnership / licensing dealCompany press release Open record12 updates